Boundless Bio Inc (BOLD) Close at $1.21 on Wednesday

Kevin Freeman

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 70300.0 shares were traded. BOLD stock price reached its highest trading level at $1.2399 during the session, while it also had its lowest trading level at $1.19.

Ratios:

We take a closer look at BOLD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.14 and its Current Ratio is at 10.14. In the meantime, Its Debt-to-Equity ratio is 0.45 whereas as Long-Term Debt/Eq ratio is at 0.42.

Upgrades & Downgrades

In the most recent recommendation for this company, H.C. Wainwright on June 02, 2025, initiated with a Buy rating and assigned the stock a target price of $5.

On May 28, 2025, Leerink Partners Downgraded its rating to Market Perform which previously was Outperform but kept the price unchanged to $3.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BOLD now has a Market Capitalization of 27086592 and an Enterprise Value of -40726204.

Stock Price History:

The Beta on a monthly basis for BOLD is -0.07, which has changed by -0.54339623 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, BOLD has reached a high of $3.12, while it has fallen to a 52-week low of $1.00. The 50-Day Moving Average of the stock is -2.95%, while the 200-Day Moving Average is calculated to be -4.62%.

Shares Statistics:

According to the various share statistics, BOLD traded on average about 169.96K shares per day over the past 3-months and 151640 shares per day over the past 10 days. A total of 22.39M shares are outstanding, with a floating share count of 15.91M. Insiders hold about 28.92% of the company’s shares, while institutions hold 39.99% stake in the company. Shares short for BOLD as of 1764288000 were 55317 with a Short Ratio of 0.42, compared to 1761868800 on 39876. Therefore, it implies a Short% of Shares Outstanding of 55317 and a Short% of Float of 0.43.

Earnings Estimates

. The current assessment of Boundless Bio Inc (BOLD) involves the perspectives of 3.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.57, with high estimates of -$0.49 and low estimates of -$0.66.

Analysts are recommending an EPS of between -$2.45 and -$2.51 for the fiscal current year, implying an average EPS of -$2.47. EPS for the following year is -$2.1, with 3.0 analysts recommending between -$1.81 and -$2.51.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.